Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Beginning Cash Balance (2021 - 2022)

Centessa Pharmaceuticals (CNTA) reported Beginning Cash Balance of $261000.0 for Q1 2022, up 2275.0% on a QoQ basis from -$12000.0 in Q4 2021.

Centessa Pharmaceuticals (CNTA) has 2 years of Beginning Cash Balance data on file, last reported at $261000.0 in Q1 2022.

  • Quarterly Beginning Cash Balance changed N/A year-over-year to $261000.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $249000.0 (changed N/A YoY) and the FY2021 annual result came in at $283000.0, changed N/A from the prior year.
  • Beginning Cash Balance rose to $261000.0 in Q1 2022 per CNTA's latest filing, from -$12000.0 in the prior quarter.
  • Across five years, Beginning Cash Balance topped out at $261000.0 in Q1 2022 and bottomed at -$12000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Centessa Pharmaceuticals 6.12 Bn 6.12 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2022 261,000.00
Mar 31, 2022 261,000.00
Dec 31, 2021 -12,000.00
Dec 31, 2021 -12,000.00